Adamas Pharmaceuticals' Series D Round

Adamas Pharmaceuticals raised a round of funding on August 15, 2009.

Adamas, formerly NeuroMolecular Pharmaceuticals, is a pharmaceutical company focused on developing small molecule, advantaged therapeutics to treat neurological and infectious diseases, including infl…

Articles about Adamas Pharmaceuticals' Series D Round: